Tactic Pharma LLC
Insider CIK 1727357 · MNPR Chief Scientific Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | S Sale | 2025-09-24 | 2025-09-26 | 550,229 | $63.61 | $35.00M | 272,026 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-04-02 | 2025-04-04 | 33,334 | $35.00 | $1.17M | 822,255 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 16,384 | $16.44 | $269.4K | 178,596 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 29,996 | $15.12 | $453.5K | 194,980 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 42,467 | $13.30 | $564.8K | 249,200 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 11,929 | $16.90 | $201.6K | 166,667 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 24,224 | $14.09 | $341.3K | 224,976 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2019-12-18 | 2019-12-20 | 125,000 | $8.00 | $1.00M | 291,667 | SEC↗ |